BioSpace News Archive

Drug Development

Trovagene Presents Data Showing Sensitivity of Triple Negative Breast Cancer (TNBC) Cell Lines to PCM-075 and Synergy with Zytiga® at San Antonio Breast Cancer Symposium (SABCS)

The presentation data indicates that PCM-075 in combination with anti-androgen, abiraterone acetate are synergistic in inducing cell death within an AR+ TNBC cell line.

December 8, 2017

·

6 min read

Lone Star Bio

Seno Medical Instruments Announces New Data Demonstrating That Imagio Opto-Acoustic Breast Imaging System Delivers Critical Diagnostic and Prognostic Information About Tumor Subtypes

The prospective, multi-center study was conducted at 16 centers in the United States.

December 8, 2017

·

5 min read

Biotech Bay

Rigel Pharma Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Rigel today announced that on December 4, 2017 the Compensation Committee of Rigel’s Board of Directors approved the grant of inducement stock options to purchase an aggregate of 60,000 shares of common stock to one new employee.

December 8, 2017

·

2 min read

Drug Development

Prolonged Progression-Free Survival Reinforces Cascadian Therapeutics’ Tucatinib’s Potential for Patients with Advanced HER2+ Metastatic Breast Cancer

Results from this analysis will be presented in a poster session at the 2017 San Antonio Breast Cancer Symposium on Friday, December 8, 2017 beginning at 5:00 p.m. CST.

December 8, 2017

·

11 min read

Biotech Bay

sRNAlytics to Accelerate its Biomarker Discovery Platform and Services at IndieBio

sRNAlytics announced today it will participate in the IndieBio Accelerator Program in San Francisco, CA.

December 8, 2017

·

3 min read

Drug Development

Sandoz Announces New Phase I Data Showing Proposed Biosimilar Pegfilgrastim Matches Reference Medicine

The Phase I study, conducted in healthy volunteers, confirmed that Sandoz biosimilar pegfilgrastim matches the reference biologic in terms of PK, PD, safety and immunogenicity profiles.

December 8, 2017

·

6 min read

ANGLE plc Announces Parsortix Potential in Metastatic Breast Cancer

ANGLE plc is delighted to announce that the University of Southern California (USC) Norris Comprehensive Cancer Center yesterday presented results of extensive work with ANGLE’s Parsortix system at the San Antonio Breast Cancer Symposium (SABCS).

December 8, 2017

·

8 min read

Biotech Beach

Genervon’s GM604 Is a Multi-Target Regulator That Provides a Novel Treatment Strategy for ALS

Genervon is presenting its recent findings at the 28th national symposium on ALS/MND in Boston on Saturday, December 9, 2017.

December 8, 2017

·

2 min read

Drug Development

Arvinas Presents New Data on Oral Estrogen Receptor PROTAC Degrader at 2017 San Antonio Breast Cancer Symposium

Arvinas today announced the presentation of new preclinical data for its novel oral estrogen receptor alpha PROTAC program during a poster session at the 2017 SABCS.

December 8, 2017

·

2 min read

Sweden’s Active Biotech is Strapped for Cash and May Not Survive 2018

The Board has also decided to sell the company’s property in Lund as a possible way of generating additional liquidity for the company.

December 8, 2017

·

2 min read